DRKS00005441招募中4 期
PROSPECTIVE, RANDOMIZED TRIAL OF TICAGRELOR VERSUS PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME - ISAR-REACT 5
Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen0 个研究点目标入组 4,000 人开始时间: 2013年11月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Patients presenting with ACS and planned invasive strategy; Informed, written consent
排除标准
- •Active bleeding; History of stroke or TIA;
- •Need for oral anticoagulation;
- •Chronic renal insufficiency requiring dialysis;
- •Moderate or severe hepatic dysfunction
研究者
相似试验
进行中（未招募）
不适用
A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS mTOR-INHIBITOR-FREE IMMUNOSUPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA - SiLVERProphylaxis against liver transplant rejection in patients undergoing liver transplantation for hepatocellular carcinoma (HCC)MedDRA version: 8.1Level: LLTClassification code 10050434EUCTR2005-005362-36-ATRegensburg University Hospital482
进行中（未招募）
不适用
A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS mTOR-INHIBITOR-FREE IMMUNOSUPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA - SiLVERProphylaxis against liver transplant rejection in patients undergoing liver transplantation for hepatocellular carcinoma (HCC)MedDRA version: 8.1Level: LLTClassification code 10050434EUCTR2005-005362-36-SERegensburg University Hospital482
进行中（未招募）
不适用
A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS mTOR-INHIBITOR-FREE IMMUNOSUPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA - SiLVERProphylaxis against liver transplant rejection in patients undergoing liver transplantation for hepatocellular carcinoma (HCC)MedDRA version: 8.1Level: LLTClassification code 10050434EUCTR2005-005362-36-GBRegensburg University Hospital482
进行中（未招募）
不适用
A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS mTOR-INHIBITOR-FREE IMMUNOSUPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA - SiLVERProphylaxis against liver transplant rejection in patients undergoing liver transplantation for hepatocellular carcinoma (HCC)MedDRA version: 8.1Level: LLTClassification code 10050434EUCTR2005-005362-36-FIRegensburg University Hospital482
进行中（未招募）
不适用
A PROSPECTIVE RANDOMISED, OPEN-LABELED, TRIAL COMPARING SIROLIMUS-CONTAINING VERSUS MTOR-INHIBITOR-FREE IMMUNOSUPPRESSION IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA - SILVERProphylaxis against liver transplant rejection in patients undergoing liver transplantation for hepatocellular carcinoma HCCMedDRA version: 6.1Level: PTClassification code 10019695EUCTR2005-005362-36-ITREGENSBURG UNIVERSITY MEDICAL CENTRE525